TRIQK
gene geneOn this page
Also known as DKFZp779L1068PRO0845LOC286144
Summary
TRIQK (triple QxxK/R motif containing, HGNC:27828) is a protein-coding gene on chromosome 8q22.1, encoding Triple QxxK/R motif-containing protein (Q629K1). May play a role in cell growth and maintenance of cell morphology.
Predicted to be located in endoplasmic reticulum membrane.
Source: NCBI Gene 286144 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_001171797
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27828 |
| Approved symbol | TRIQK |
| Name | triple QxxK/R motif containing |
| Location | 8q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp779L1068, PRO0845, LOC286144 |
| Ensembl gene | ENSG00000205133 |
| Ensembl biotype | protein_coding |
| Entrez | 286144 |
Gene structure
Transcript identifiers
Ensembl transcripts: 53 — 46 protein_coding, 5 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000378861, ENST00000517540, ENST00000517751, ENST00000517858, ENST00000518400, ENST00000518748, ENST00000519069, ENST00000519792, ENST00000519969, ENST00000520384, ENST00000520430, ENST00000520686, ENST00000521617, ENST00000521988, ENST00000522903, ENST00000522925, ENST00000523060, ENST00000523375, ENST00000523580, ENST00000524037, ENST00000524107, ENST00000524260, ENST00000537541, ENST00000884571, ENST00000884572, ENST00000884573, ENST00000884574, ENST00000884575, ENST00000884576, ENST00000884577, ENST00000884578, ENST00000884579, ENST00000884580, ENST00000884581, ENST00000884582, ENST00000884583, ENST00000884584, ENST00000884585, ENST00000884586, ENST00000884587, ENST00000884588, ENST00000884589, ENST00000923118, ENST00000923119, ENST00000923120, ENST00000923121, ENST00000971347, ENST00000971348, ENST00000971349, ENST00000971350, ENST00000971351, ENST00000971352, ENST00000971353
RefSeq mRNA: 7 — MANE Select: NM_001171797
NM_001171795, NM_001171796, NM_001171797, NM_001171798, NM_001171799, NM_001191035, NM_001191036
CCDS: CCDS55261
Canonical transcript exons
ENST00000521988 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001479063 | 92954406 | 92954564 |
| ENSE00002093361 | 92916929 | 92917010 |
| ENSE00002113664 | 92883534 | 92886735 |
| ENSE00002122882 | 92966007 | 92966144 |
| ENSE00003524421 | 92891989 | 92892074 |
Expression profiles
Bgee: expression breadth ubiquitous, 247 present calls, max score 95.02.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.3892 / max 302.5516, expressed in 1728 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 93957 | 9.9899 | 1653 |
| 93954 | 6.5521 | 1556 |
| 93953 | 3.8585 | 1375 |
| 93955 | 2.0128 | 1080 |
| 93956 | 0.9108 | 589 |
| 93952 | 0.6556 | 375 |
| 93951 | 0.3393 | 140 |
| 93959 | 0.0636 | 16 |
| 93960 | 0.0066 | 5 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| epithelial cell of pancreas | CL:0000083 | 95.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.73 | gold quality |
| cortical plate | UBERON:0005343 | 94.31 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.79 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 93.37 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 93.30 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.68 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.51 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 91.83 | gold quality |
| tibia | UBERON:0000979 | 91.72 | gold quality |
| gall bladder | UBERON:0002110 | 91.17 | gold quality |
| monocyte | CL:0000576 | 91.15 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 90.68 | gold quality |
| leukocyte | CL:0000738 | 90.59 | gold quality |
| myocardium | UBERON:0002349 | 89.98 | gold quality |
| parietal pleura | UBERON:0002400 | 89.74 | gold quality |
| kidney epithelium | UBERON:0004819 | 89.52 | silver quality |
| rectum | UBERON:0001052 | 89.15 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.09 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.95 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 88.89 | gold quality |
| medial globus pallidus | UBERON:0002477 | 88.82 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 88.79 | gold quality |
| bronchus | UBERON:0002185 | 88.55 | gold quality |
| endothelial cell | CL:0000115 | 88.53 | gold quality |
| ileal mucosa | UBERON:0000331 | 88.46 | gold quality |
| globus pallidus | UBERON:0001875 | 88.33 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 87.89 | gold quality |
| primary visual cortex | UBERON:0002436 | 87.79 | gold quality |
| corpus callosum | UBERON:0002336 | 87.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
180 targeting TRIQK, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | triqk | ENSDARG00000076296 |
| mus_musculus | Triqk | ENSMUSG00000055963 |
| rattus_norvegicus | Triqk | ENSRNOG00000039924 |
Protein
Protein identifiers
Triple QxxK/R motif-containing protein — Q629K1 (reviewed: Q629K1)
Alternative names: Triple repetitive-sequence of QXXK/R protein homolog
All UniProt accessions (5): A0A1Y8EM41, E5RG44, E5RGJ1, E5RIT1, Q629K1
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in cell growth and maintenance of cell morphology.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the TRIQK family.
RefSeq proteins (7): NP_001165266, NP_001165267, NP_001165268, NP_001165269, NP_001165270, NP_001177964, NP_001177965 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024842 | TRIQK | Family |
Pfam: PF15168
UniProt features (2 total): chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q629K1-F1 | 74.72 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 102 (showing top):
GOZGIT_ESR1_TARGETS_DN, chr8q22, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, MEISSNER_ES_ICP_WITH_H3K4ME3, MEISSNER_NPC_ICP_WITH_H3K4ME3, MEISSNER_BRAIN_ICP_WITH_H3K4ME3, KOYAMA_SEMA3B_TARGETS_DN, GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN, FORTSCHEGGER_PHF8_TARGETS_DN, NKX2_2_TARGET_GENES, ZNF407_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
220 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIQK | OR5AU1 | Q8NGC0 | 570 |
| TRIQK | FBLL1 | A6NHQ2 | 452 |
| TRIQK | MFSD2B | A6NFX1 | 445 |
| TRIQK | RTL8B | Q17RB0 | 441 |
| TRIQK | RNASEK | Q6P5S7 | 433 |
| TRIQK | THSD1 | Q9NS62 | 425 |
| TRIQK | TMEM51 | Q9NW97 | 410 |
| TRIQK | C9JE84 | C9JE84 | 400 |
| TRIQK | SERTM1 | A2A2V5 | 380 |
| TRIQK | CDC42EP5 | Q6NZY7 | 374 |
| TRIQK | NPTXR | O95502 | 374 |
| TRIQK | FEZ2 | Q9UHY8 | 374 |
| TRIQK | CFAP44 | Q96MT7 | 370 |
| TRIQK | PCDHGA9 | Q9Y5G4 | 366 |
| TRIQK | PPEF2 | O14830 | 350 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC30A10 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): TRIQK (Affinity Capture-RNA), TRIQK (Positive Genetic), TRIQK (Cross-Linking-MS (XL-MS)), TRIQK (Cross-Linking-MS (XL-MS)), TRIQK (Affinity Capture-MS), TRIQK (Proximity Label-MS), TRIQK (Proximity Label-MS), TRIQK (Proximity Label-MS)
ESM2 similar proteins: A2VDA9, A4IG59, A5WVU9, B0BN56, B0WN94, B2B9D9, B2B9E1, B3DHH5, C5DIL2, F4HVZ5, O22912, P52870, P52871, P82925, P92204, Q09JL7, Q0IFA9, Q22472, Q28DN4, Q42841, Q53HL2, Q553P6, Q56JY4, Q5EB66, Q5I030, Q5RBS5, Q5RDR6, Q5U4A3, Q5ZKA6, Q60ZR7, Q61733, Q629K1, Q68EU0, Q6AXW0, Q6AZH0, Q6CJX5, Q7PH91, Q8J2P4, Q8SY72, Q8VY39
Diamond homologs: A5WVU9, B2B9D9, B2B9E1, Q5EB66, Q5RDR6, Q629K1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2709 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:92892308:C:CT | acceptor_gain | 1.0000 |
| 8:92916923:GCTTA:G | donor_loss | 1.0000 |
| 8:92916924:CTTA:C | donor_loss | 1.0000 |
| 8:92916925:TT:T | donor_loss | 1.0000 |
| 8:92916926:TA:T | donor_loss | 1.0000 |
| 8:92916927:A:AC | donor_gain | 1.0000 |
| 8:92916927:A:T | donor_loss | 1.0000 |
| 8:92916928:C:CA | donor_loss | 1.0000 |
| 8:92916928:C:CC | donor_gain | 1.0000 |
| 8:92954561:CTTA:C | acceptor_gain | 1.0000 |
| 8:92891983:GTTTA:G | donor_loss | 0.9900 |
| 8:92891984:TTTA:T | donor_loss | 0.9900 |
| 8:92891985:TTACC:T | donor_loss | 0.9900 |
| 8:92891986:TACCT:T | donor_loss | 0.9900 |
| 8:92891987:A:C | donor_loss | 0.9900 |
| 8:92891988:C:CA | donor_loss | 0.9900 |
| 8:92892074:CCTAG:C | acceptor_loss | 0.9900 |
| 8:92892075:C:CC | acceptor_gain | 0.9900 |
| 8:92892076:T:A | acceptor_loss | 0.9900 |
| 8:92892161:A:AC | donor_gain | 0.9900 |
| 8:92892162:C:CC | donor_gain | 0.9900 |
| 8:92892219:TGTC:T | donor_gain | 0.9900 |
| 8:92916928:CCAA:C | donor_gain | 0.9900 |
| 8:92916928:CCAAT:C | donor_gain | 0.9900 |
| 8:92917006:GCCTG:G | acceptor_gain | 0.9900 |
| 8:92917007:CCTGC:C | acceptor_gain | 0.9900 |
| 8:92917008:CTG:C | acceptor_gain | 0.9900 |
| 8:92917009:TG:T | acceptor_gain | 0.9900 |
| 8:92930628:G:C | donor_gain | 0.9900 |
| 8:92954528:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000024676 (8:92943832 T>C), RS1000025671 (8:92987904 A>G), RS1000032715 (8:92900726 C>A), RS1000037489 (8:93018214 T>C), RS1000091729 (8:92997803 T>C,G), RS1000094811 (8:92945189 C>A), RS1000104421 (8:92929575 C>T), RS1000133063 (8:92908125 A>C), RS1000133408 (8:92953604 G>A), RS1000141007 (8:92950032 A>G), RS1000194285 (8:92981841 A>C,G), RS1000214688 (8:92950384 A>C), RS1000226831 (8:93014433 A>G), RS1000262970 (8:92891642 C>A), RS1000284090 (8:92925948 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006994_2 | Logical memory (immediate recall) in Alzheimer’s disease dementia | 4.000000e-07 |
| GCST007576_259 | Chronotype | 9.000000e-12 |
| GCST007626_6 | Lack of perseverance | 7.000000e-07 |
| GCST010307_8 | Urinary albumin excretion | 2.000000e-08 |
| GCST010550_2 | Acute ischemic stroke x type 2 diabetes interaction | 3.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0008328 | chronotype measurement |
| EFO:0006946 | behavioural disinhibition measurement |
| EFO:0004285 | albuminuria |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| alpha-pinene | affects cotreatment, increases expression, increases abundance | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases expression, increases abundance | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases expression, increases response to substance | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acrolein | affects cotreatment, increases expression, increases abundance | 1 |
| Air Pollutants | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.